160 related articles for article (PubMed ID: 12054073)
21. The new varicella vaccine: efficacy, safety, and administration.
Sparks L; Russell C
J Pediatr Nurs; 1998 Apr; 13(2):85-94. PubMed ID: 9581419
[TBL] [Abstract][Full Text] [Related]
22. Universal varicella vaccine immunization in Japan.
Yoshikawa T; Kawamura Y; Ohashi M
Vaccine; 2016 Apr; 34(16):1965-70. PubMed ID: 26944711
[TBL] [Abstract][Full Text] [Related]
23. [Immunization against varicella and zoster].
Floret D
Bull Acad Natl Med; 2007 Jun; 191(6):1051-64; discussion 1064-7. PubMed ID: 18402164
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
25. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.
Ota K; Kim V; Lavi S; Ford-Jones EL; Tipples G; Scolnik D; Tellier R
Pediatr Infect Dis J; 2008 Sep; 27(9):847-8. PubMed ID: 18664930
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
[TBL] [Abstract][Full Text] [Related]
27. Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial.
Dubey AP; Faridi MMA; Mitra M; Kaur IR; Dabas A; Choudhury J; Mukherjee M; Mishra D
Hum Vaccin Immunother; 2017 Sep; 13(9):2032-2037. PubMed ID: 28509605
[TBL] [Abstract][Full Text] [Related]
28. Varicella vaccine effectiveness in the US vaccination program: a review.
Seward JF; Marin M; Vázquez M
J Infect Dis; 2008 Mar; 197 Suppl 2():S82-9. PubMed ID: 18419415
[TBL] [Abstract][Full Text] [Related]
29. Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine.
;
MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(10):258-60. PubMed ID: 18340332
[TBL] [Abstract][Full Text] [Related]
30. Live virus immunization after orthotopic liver transplantation.
Khan S; Erlichman J; Rand EB
Pediatr Transplant; 2006 Feb; 10(1):78-82. PubMed ID: 16499592
[TBL] [Abstract][Full Text] [Related]
31. Safety of a refrigerator-stable varicella vaccine (VARIVAX) in healthy 12- to 15-month-old children: A randomized, double-blind, cross-over study.
Ferrera G; Gajdos V; Thomas S; Tran C; Fiquet A
Hum Vaccin; 2009 Jul; 5(7):455-60. PubMed ID: 19305145
[TBL] [Abstract][Full Text] [Related]
32. [Varicella vaccination update].
Nürnberg W; Schneeweiss B
J Dtsch Dermatol Ges; 2006 Jul; 4(7):540-3. PubMed ID: 16827911
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the Whole-Genome Sequence of an Oka Varicella Vaccine from China with Other Oka Vaccine Strains Reveals Sites Putatively Critical for Vaccine Efficacy.
Wu Q; Rivailler P; Xu S; Xu W
J Virol; 2019 May; 93(9):. PubMed ID: 30728261
[TBL] [Abstract][Full Text] [Related]
34. Safety of a second dose of varicella vaccine administered at 4 to 6 years of age in healthy children in Argentina.
Fridman D; Monti A; Bonnet MC; Armoni J; Stamboulian D
Hum Vaccin; 2011 Oct; 7(10):1066-71. PubMed ID: 21989288
[TBL] [Abstract][Full Text] [Related]
35. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1996 Jul; 45(RR-11):1-36. PubMed ID: 8668119
[TBL] [Abstract][Full Text] [Related]
36. Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects > or =13 years of age.
Diaz C; Dentico P; Gonzalez R; Mendez RG; Cinquetti S; Barben JL; Harmon A; Chalikonda I; Smith JG; Stek JE; Robertson A; Caulfield MJ; Biasio LR; Silber JL; Chan CY; Vessey R; Sadoff J; Chan IS; Matthews H; Wang W; Schlienger K; Schödel FP;
Vaccine; 2006 Nov; 24(47-48):6875-85. PubMed ID: 17050042
[TBL] [Abstract][Full Text] [Related]
37. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
Goh P; Lim FS; Han HH; Willems P
Infection; 2007 Oct; 35(5):326-33. PubMed ID: 17710370
[TBL] [Abstract][Full Text] [Related]
38. The varicella vaccine. An evolving mosaic of information.
Zannolli R; Morgese G
Panminerva Med; 1996 Mar; 38(1):28-32. PubMed ID: 8766876
[TBL] [Abstract][Full Text] [Related]
39. Herpes zoster vaccine (Zostavax).
Med Lett Drugs Ther; 2006 Sep; 48(1243):73-4. PubMed ID: 16977285
[TBL] [Abstract][Full Text] [Related]
40. Review of recommendations of the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, on varicella vaccine.
Holmes SJ
J Infect Dis; 1996 Nov; 174 Suppl 3():S342-4. PubMed ID: 8896543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
